303 related articles for article (PubMed ID: 31615852)
1. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
[TBL] [Abstract][Full Text] [Related]
2. Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.
Lablanche S; Borot S; Wojtusciszyn A; Bayle F; Tétaz R; Badet L; Thivolet C; Morelon E; Frimat L; Penfornis A; Kessler L; Brault C; Colin C; Tauveron I; Bosco D; Berney T; Benhamou PY;
Diabetes Care; 2015 Sep; 38(9):1714-22. PubMed ID: 26068866
[TBL] [Abstract][Full Text] [Related]
3. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
[TBL] [Abstract][Full Text] [Related]
4. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
Deng S; Markmann JF; Rickels M; Yeh H; Kim JI; Lian MM; Gu Y; Markmann E; Palanjian M; Barker CF; Naji A
Transplantation; 2009 Sep; 88(6):820-5. PubMed ID: 19920782
[TBL] [Abstract][Full Text] [Related]
5. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.
Hering BJ; Clarke WR; Bridges ND; Eggerman TL; Alejandro R; Bellin MD; Chaloner K; Czarniecki CW; Goldstein JS; Hunsicker LG; Kaufman DB; Korsgren O; Larsen CP; Luo X; Markmann JF; Naji A; Oberholzer J; Posselt AM; Rickels MR; Ricordi C; Robien MA; Senior PA; Shapiro AM; Stock PG; Turgeon NA;
Diabetes Care; 2016 Jul; 39(7):1230-40. PubMed ID: 27208344
[TBL] [Abstract][Full Text] [Related]
6. Primary graft function, metabolic control, and graft survival after islet transplantation.
Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
[TBL] [Abstract][Full Text] [Related]
7. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
[TBL] [Abstract][Full Text] [Related]
8. Indications for clinical islet transplantation today and in the forseeable future--the diabetologist's point of view.
Federlin K; Pozza G
J Mol Med (Berl); 1999 Jan; 77(1):148-52. PubMed ID: 9930951
[TBL] [Abstract][Full Text] [Related]
9. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
[TBL] [Abstract][Full Text] [Related]
10. Glycemia, Hypoglycemia, and Costs of Simultaneous Islet-Kidney or Islet After Kidney Transplantation Versus Intensive Insulin Therapy and Waiting List for Islet Transplantation.
Gerber PA; Locher R; Zuellig RA; Tschopp O; Ajdler-Schaeffler E; Kron P; Oberkofler C; Brändle M; Spinas GA; Lehmann R
Transplantation; 2015 Oct; 99(10):2174-80. PubMed ID: 25905979
[TBL] [Abstract][Full Text] [Related]
11. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
[TBL] [Abstract][Full Text] [Related]
12. Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up.
Lehmann R; Graziano J; Brockmann J; Pfammatter T; Kron P; de Rougemont O; Mueller T; Zuellig RA; Spinas GA; Gerber PA
Diabetes Care; 2015 May; 38(5):752-9. PubMed ID: 25665814
[TBL] [Abstract][Full Text] [Related]
13. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.
Kessler L; Passemard R; Oberholzer J; Benhamou PY; Bucher P; Toso C; Meyer P; Penfornis A; Badet L; Wolf P; Colin C; Morel P; Pinget M;
Diabetes Care; 2002 Dec; 25(12):2256-62. PubMed ID: 12453970
[TBL] [Abstract][Full Text] [Related]
14. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
15. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
[TBL] [Abstract][Full Text] [Related]
16. [End-stage nephropathy in type 1-diabetes mellitus - kidney transplantation alone or combined with islet or pancreas transplantation?].
Lehman R; Gerber PA
Ther Umsch; 2011 Dec; 68(12):699-706. PubMed ID: 22139985
[TBL] [Abstract][Full Text] [Related]
17. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
[TBL] [Abstract][Full Text] [Related]
18. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR).
CITR Research Group
Cell Transplant; 2009; 18(7):753-67. PubMed ID: 19796497
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up after clinical islet transplantation.
Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
[TBL] [Abstract][Full Text] [Related]
20. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
